Inborn Errors Working Party - EBMT Errors Working Party.pdf1 #EBMT20Virtual Haematopoietic Cell...

1
www.ebmt.org #EBMT20Virtual 1 Haematopoietic Cell Transplantation in Chronic Granulomatous Disease: a Study on 712 Children and Adults Blood 2020 Chiesa R,. Wang J., Blok H.J., Hazelaar S., Neven B., Moshous D., Schulz A.S., Hoenig M., Hauck F., Al Seraihy A., Gozdzik J., Ljungman P.T., Lindemans C., Fernandes J., Kalwak K., Strahm B., Schanz U., Sedlacek P., Sykora K.W., Aksoylar S., Locatelli F., Stepensky P., Wynn R.F., Lum S.H., Zecca M., Porta F., Taskinen M.H., Gibson B.E., Matthes-Martin S., Karakukcu M., Hauri-Hohl M.M., Veys P., Gennery A.R., Lucchini G., Felber M., Albert M.H., Balashov D., Lankester A.C., Güngör T., Slatter M. Hematopoietic stem cell transplantation for CD40 ligand deficiency: results from an EBMT/ESID-IEWP- SCETIDE-PIDTC Study J Allergy Clin Immunol 2019 Ferrua F., Galimberti S., Courteille V., Slatter M.A., Booth C., Moshous D., Neven B., Blanche S., Cavazzana M., Laberko A., Shcherbina A., Balashov D., Soncini E., Porta F., Al-Mousa H., Al-Saud B., Al-Dhekri H., Arnaout R., Formankova R., Bertrand Y., Lange A., Smart J., Wolska-Kusnierz B., Aquino V.M., Dvorak C.C., Fasth A., Fouyssac F., Heilmann C., Hoenig M., Schuetz C., Kelecic J., Bredius R.G.M., Lankester A.C., Lindemans C.A., Suarez F., Sullivan K.E., Albert M.H., Kalwak K., Barlogis V., Bhatia M., Bordon V., Czogala W., Alonso L., Dogu F., Gozdzik J., Ikinciogullari A., Krivan G., Ljungman P., Meyts I., Mustillo P., Smith A.R., Speckmann C., Sundin M., Keogh S.J., Shaw P.J., Boelens J.J., Schulz A.S., Sedlacek P., Veys P., Mahlaoui N., Janda A., Davies E.G., Fischer A., Cowan M.J., Gennery A.R. Hematopoietic Stem Cell Transplantation for Primary Immunodeficiencies Front Pediatr 2019 Gennery, A. R., Albert M. H., Slatter M. A., and Lankester A. Hematopoietic Cell Transplantation for MHC Class II Deficiency Front Pediatr 2019 Lum, S. H., Neven B., Slatter M. A., and Gennery, A. R. Conditioning perspectives for Primary Immunodeficiency Stem Cell Transplants Front Pediatr 2019 Shaw, P., Shizuru J., Hoenig M., and Veys P. Hematopoietic Stem Cell Transplantation in Inborn Errors of Metabolism Front Pediatr 2019 Tan, E. Y., Boelens J. J., Jones S. A., and Wynn R. F. Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Immune Dysregulatory Disorders Front Pediatr 2019 Bakhtiar, S., Fekadu J., Seidel M. G., and Gambinieri E. Wiskott -Aldrich Syndrome (WAS) and Dedicator of Cytokinesis 8- (DOCK8) Deficiency Front Pediatr 2019 Albert, M. H., & Freeman A. F. The Evidence for Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Neutrophil Disorders: A Comprehensive Review by the Inborn Errors Working Party Group of the EBMT Front Pediatr 2019 Bakhtiar, S., Shadur, B., and Stepensky, P. Long Term Outcome and Immune Function After Hematopoietic Stem Cell Transplantation for Primary Immunodeficiency Front Pediatr 2019 Gennery, A. R., Lankester, A. Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working Parties Front Pediatr 2019 Greco R., Labopin M., Badoglio M., Veys P., Furtado Silva J.M., Abinun M., Gualandi F., Bornhauser M., Ciceri F., Saccardi R., Lankester A., Alexander T., Gennery A.R., Bader P., Farge D., Snowden J.A. Universal Newborn Screening for Severe Combined Immunodeficiency (SCID) Front Pediatr 2019 van der Burg M., Mahlaoui N., Gaspar H.B., Pai S-Y. Allogeneic HSCT in Adolescents and Young Adults With Primary Immunodeficiencies Front Pediatr 2019 Morris E.C., Albert M.H. Haematopoietic Stem Cell Transplantation for Primary Haemophagocytic Lymphohistiocytosis Front Pediatr 2019 Lehmberg K., Moshous D., Booth C. Arjan Lankester (chair) Leiden, the Netherlands Michael Albert (secretary/co-chair) Munich, Germany Inborn Errors Working Party Arjan Lankester Chair [email protected] Yvonne Wijkhuisen Secretary A. Lankester Y.W.Wijkhuisen[email protected] Michael Albert Secretary/Co-Chair [email protected] -muenchen.de Sheree Hazelaar EBMT Data manager [email protected] Recent Publications on behalf of IEWP Studies EBMT Registry Virtual IEWP events Future Events 2020 Contact IEWP Topic* Disease type Joint AYA PID PID Haplo in PID PID ICF Syndrome PID IFNg R1 R2 PID Allo in MLD PID Second Allo PID Mevalonate Kinase Deficiency PID CD27/CD70 deficiency PID IEWP ESID * If you whish to participate in data collection for these studies, please contact: [email protected] Tuesday September 1 st IEWP session 11.00 12.00 Auditorium 4 Program IEWP session: 11.00 11.12 Landscape of GT and allogeneic Therapy in IEM: The next years - Robert Wynn 11.12 11.24 Therapeutic standards for patients with SCID- still a matter of discussion - Manfred Hönig 11.24 11.36 Induction therapy in Inborn Errors of Immunity before HSCT Victoria Tesch 11.36 11.48 Inflammation and autoimmunity in PID: Does it matter for HSCT? - Bénédicte Neven 11.48 12.00 Discussion Significant Collaborations

Transcript of Inborn Errors Working Party - EBMT Errors Working Party.pdf1 #EBMT20Virtual Haematopoietic Cell...

Page 1: Inborn Errors Working Party - EBMT Errors Working Party.pdf1 #EBMT20Virtual Haematopoietic Cell Transplantation in Chronic Granulomatous Disease: a Study on 712 Children and Adults

www.ebmt.org #EBMT20Virtual1

Haematopoietic Cell Transplantation in Chronic Granulomatous Disease: a Study on 712 Children and

Adults Blood 2020

Chiesa R,. Wang J., Blok H.J., Hazelaar S., Neven B., Moshous D., Schulz A.S., Hoenig M., Hauck F., Al Seraihy

A., Gozdzik J., Ljungman P.T., Lindemans C., Fernandes J., Kalwak K., Strahm B., Schanz U., Sedlacek P., Sykora

K.W., Aksoylar S., Locatelli F., Stepensky P., Wynn R.F., Lum S.H., Zecca M., Porta F., Taskinen M.H., Gibson

B.E., Matthes-Martin S., Karakukcu M., Hauri-Hohl M.M., Veys P., Gennery A.R., Lucchini G., Felber M., Albert

M.H., Balashov D., Lankester A.C., Güngör T., Slatter M.

Hematopoietic stem cell transplantation for CD40 ligand deficiency: results from an EBMT/ESID-IEWP-

SCETIDE-PIDTC Study J Allergy Clin Immunol 2019

Ferrua F., Galimberti S., Courteille V., Slatter M.A., Booth C., Moshous D., Neven B., Blanche S., Cavazzana M.,

Laberko A., Shcherbina A., Balashov D., Soncini E., Porta F., Al-Mousa H., Al-Saud B., Al-Dhekri H., Arnaout R.,

Formankova R., Bertrand Y., Lange A., Smart J., Wolska-Kusnierz B., Aquino V.M., Dvorak C.C., Fasth A.,

Fouyssac F., Heilmann C., Hoenig M., Schuetz C., Kelecic J., Bredius R.G.M., Lankester A.C., Lindemans C.A.,

Suarez F., Sullivan K.E., Albert M.H., Kalwak K., Barlogis V., Bhatia M., Bordon V., Czogala W., Alonso L., Dogu F.,

Gozdzik J., Ikinciogullari A., Krivan G., Ljungman P., Meyts I., Mustillo P., Smith A.R., Speckmann C., Sundin M.,

Keogh S.J., Shaw P.J., Boelens J.J., Schulz A.S., Sedlacek P., Veys P., Mahlaoui N., Janda A., Davies E.G.,

Fischer A., Cowan M.J., Gennery A.R.

Hematopoietic Stem Cell Transplantation for Primary Immunodeficiencies Front Pediatr 2019

Gennery, A. R., Albert M. H., Slatter M. A., and Lankester A.

Hematopoietic Cell Transplantation for MHC Class II Deficiency Front Pediatr 2019

Lum, S. H., Neven B., Slatter M. A., and Gennery, A. R.

Conditioning perspectives for Primary Immunodeficiency Stem Cell Transplants Front Pediatr 2019

Shaw, P., Shizuru J., Hoenig M., and Veys P.

Hematopoietic Stem Cell Transplantation in Inborn Errors of Metabolism Front Pediatr 2019

Tan, E. Y., Boelens J. J., Jones S. A., and Wynn R. F.

Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Immune Dysregulatory Disorders Front

Pediatr 2019

Bakhtiar, S., Fekadu J., Seidel M. G., and Gambinieri E.

Wiskott-Aldrich Syndrome (WAS) and Dedicator of Cytokinesis 8- (DOCK8) Deficiency Front Pediatr 2019

Albert, M. H., & Freeman A. F.

The Evidence for Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Neutrophil Disorders:

A Comprehensive Review by the Inborn Errors Working Party Group of the EBMT Front Pediatr 2019

Bakhtiar, S., Shadur, B., and Stepensky, P.

Long Term Outcome and Immune Function After Hematopoietic Stem Cell Transplantation for Primary

Immunodeficiency Front Pediatr 2019

Gennery, A. R., Lankester, A.

Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and

PDWP Working Parties Front Pediatr 2019

Greco R., Labopin M., Badoglio M., Veys P., Furtado Silva J.M., Abinun M., Gualandi F., Bornhauser M., Ciceri F.,

Saccardi R., Lankester A., Alexander T., Gennery A.R., Bader P., Farge D., Snowden J.A.

Universal Newborn Screening for Severe Combined Immunodeficiency (SCID) Front Pediatr 2019

van der Burg M., Mahlaoui N., Gaspar H.B., Pai S-Y.

Allogeneic HSCT in Adolescents and Young Adults With Primary Immunodeficiencies Front Pediatr 2019

Morris E.C., Albert M.H.

Haematopoietic Stem Cell Transplantation for Primary Haemophagocytic Lymphohistiocytosis Front

Pediatr 2019

Lehmberg K., Moshous D., Booth C.

Arjan Lankester (chair) Leiden, the Netherlands

Michael Albert (secretary/co-chair) Munich, Germany

Inborn Errors

Working Party

Arjan Lankester Chair [email protected]

Yvonne Wijkhuisen Secretary A. Lankester [email protected]

Michael Albert Secretary/Co-Chair [email protected]

Sheree Hazelaar EBMT Data manager [email protected]

Recent Publications on behalf of IEWP

StudiesEBMT Registry

Virtual IEWP events

Future Events 2020

Contact IEWP

Topic* Disease type Joint

AYA PID PID

Haplo in PID PID

ICF Syndrome PID

IFNg R1 R2 PID

Allo in MLD PID

Second Allo PID

Mevalonate Kinase

DeficiencyPID

CD27/CD70 deficiency PID IEWP – ESID

* If you whish to participate in data collection for these studies, please contact:

[email protected]

Tuesday September 1st

IEWP session

11.00 – 12.00

Auditorium 4

Program IEWP session:

▪ 11.00 – 11.12 Landscape of GT and allogeneic Therapy in IEM: The

next years - Robert Wynn

▪ 11.12 – 11.24 Therapeutic standards for patients with SCID- still a

matter of discussion - Manfred Hönig

▪ 11.24 – 11.36 Induction therapy in Inborn Errors of Immunity before

HSCT – Victoria Tesch

▪ 11.36 – 11.48 Inflammation and autoimmunity in PID: Does it matter for

HSCT? - Bénédicte Neven

▪ 11.48 – 12.00 Discussion

Significant Collaborations